Skip to content
value.today

CardioFocus, Inc.

Total raised
$153 M
13 rounds on record
Latest round
$27 M
Feb 2023
First round on record
Jun 2009
Today
Private
No later event on record

Funding rounds

13 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of CardioFocus, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2023$27 MNo. 13$10 to $50 million

CardioFocus, Inc.: Raise no. 13, Feb 2023

Investors in this round

4 investors had bought by the notice of Feb 24, 2023: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$27 M of $32 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Scott Fletcher · Executive Officer
  • Stephan Ogilvie · Executive Officer
  • Bruce Robertson · Director
  • Charles Larsen · Director
  • David Kho · Director
  • Gwen Watanabe · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Scott Fletcher, Vice President of Finance & Administration. Source: SEC Form D, newest notice filed Feb 24, 2023. Read the notice at the SEC.

equity, debtSEC
Mar 2022$4 MNo. 12$2 to $10 million

CardioFocus, Inc.: Raise no. 12, Mar 2022

Investors in this round

12 investors had bought by the notice of Apr 12, 2022: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $50 M offered; $46 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Burke Barrett · Executive Officer, Director
  • Stephan Ogilvie · Executive Officer
  • Bruce Robertson · Director
  • Charles Larsen · Director
  • Omar Amirana · Director
  • Patrick Wethington · Director
  • Paul LaViolette · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Burke Barrett, CEO & President. Source: SEC Form D, newest notice filed Apr 12, 2022. Read the notice at the SEC.

equitySEC
Jul 2020$12 MNo. 11$10 to $50 million

CardioFocus, Inc.: Raise no. 11, Jul 2020

Investors in this round

13 investors had bought by the notice of Jul 20, 2020: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $15 M offered; $3 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Burke Barrett · Executive Officer, Director
  • Bruce Robertson · Director
  • Charles Larsen · Director
  • Omar Amirana · Director
  • Patrick Wethington · Director
  • Paul LaViolette · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Burke Barrett, CEO & President. Source: SEC Form D, newest notice filed Jul 20, 2020. Read the notice at the SEC.

equitySEC
May 2019$8 MNo. 10$2 to $10 million

CardioFocus, Inc.: Raise no. 10, May 2019

Investors in this round

17 investors had bought by the notice of May 20, 2019: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $12 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Burke C. Barrett · Executive Officer
  • Omari C. Bouknight · Executive Officer
  • Bruce C. Robertson · Director
  • Charles E. Larsen · Director
  • Christopher A. Kroeger · Director
  • Greg C. Madden · Director
  • Omar C. Amirana · Director
  • Patrick C. Wethington · Director
  • Paul C. Laviolette · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Scott Fletcher, Vp finance & admin. Source: SEC Form D, newest notice filed May 20, 2019. Read the notice at the SEC.

equity, optionsSEC
Apr 2018$13 MNo. 9$10 to $50 million

CardioFocus, Inc.: Raise no. 9, Apr 2018

Investors in this round

1 investor had bought by the notice of Apr 18, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $21 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,600,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Burke R. Barrett · Executive Officer
  • Paul C. Laviolette · Executive Officer, Director
  • Warren R. Clark, Iii · Executive Officer
  • Bruce C. Robertson · Director
  • Charles E. Larsen · Director
  • Christopher A. Kroeger · Director
  • Greg R. Madden · Director
  • Omar C. Amirana · Director
  • Patrick R. Wethington · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • TRUMP SECURITIES LLC (CRD 47107) · New York, New YorkSold in NY

Signed by Warren R. Clark, Iii, Cfo. Source: SEC Form D and 1 amendment, newest notice filed Apr 18, 2018. Read the notice at the SEC.

debt, optionsSEC
Feb 2017$20 MNo. 8$10 to $50 million

CardioFocus, Inc.: Raise no. 8, Feb 2017

Investors in this round

26 investors had bought by the notice of Mar 1, 2017: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $32 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Burke J. Barrett · Executive Officer
  • Paul C. Laviolette · Executive Officer, Director
  • Warren C. Clark, Iii · Executive Officer
  • Bruce C. Robertson · Director
  • Charles Larsen · Director
  • Christopher Kroeger · Director
  • James Garvey · Director
  • Omar C. Amirana · Director
  • Patrick J. Wethington · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Warren Clark, Iii, Cfo. Source: SEC Form D, newest notice filed Mar 1, 2017. Read the notice at the SEC.

equity, optionsSEC
May 2016$8 MNo. 7$2 to $10 million

CardioFocus, Inc.: Raise no. 7, May 2016

Investors in this round

0 investors had bought by the notice of May 18, 2016: 0 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $12 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, other: CONVERTIBLE DEBT
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Warren R. Clark, Iii · Executive Officer
  • Bruce C. Robertson · Director
  • Charles E. Larsen · Director
  • Christopher A. Kroeger · Director
  • James E. Garvey · Director
  • Omar C. Anirana · Director
  • Paul C. Laviolette · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Warren R. Clark, Iii, Cfo. Source: SEC Form D, newest notice filed May 18, 2016. Read the notice at the SEC.

equity, debtSEC
Dec 2014$32 MNo. 6$10 to $50 million

CardioFocus, Inc.: Raise no. 6, Dec 2014

Investors in this round

32 investors had bought by the notice of Jan 6, 2015: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$32 M of $33 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Preferred Stock can convert to Common Stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anjie Roldan · Executive Officer
  • Lauren Jennings · Executive Officer
  • Paul LaViolette · Executive Officer, Director
  • Stephen Sagon · Executive Officer, Director
  • Warren Clark · Executive Officer
  • Bruce Robertson · Director
  • Charles Larsen · Director
  • Christopher Kroeger · Director
  • James Garvey · Director
  • Omar Amirana · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “A portion of the proceeds were satisfied through conversion of Promissory Notes.”

Signed by Stephen Sagon, President. Source: SEC Form D, newest notice filed Jan 6, 2015. Read the notice at the SEC.

equitySEC
Nov 2014$2 MNo. 5$2 to $10 million

CardioFocus, Inc.: Raise no. 5, Nov 2014

Investors in this round

29 investors had bought by the notice of Nov 13, 2014: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, other: Convertible debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen W Sagon · Executive Officer, Director
  • Warren R Clark III · Executive Officer
  • Bruce C Robertson · Director
  • Charles E Larsen · Director
  • Christopher A Kroeger · Director
  • James E Garvey · Director
  • Omar R Amirana · Director
  • Paul C LaViolette · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen W. Sagon, President. Source: SEC Form D, newest notice filed Nov 13, 2014. Read the notice at the SEC.

equity, debtSEC
Apr 2014$2 MNo. 4$2 to $10 million

CardioFocus, Inc.: Raise no. 4, Apr 2014

Investors in this round

27 investors had bought by the notice of May 9, 2014: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, other: Convertible Debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David R. Kressler · Executive Officer · Director of Medical Devices
  • Paul W. Laviolette · Executive Officer, Director
  • Stephen W. Sagon · Executive Officer, Director
  • Warren R. Clark III · Executive Officer
  • Bruce W. Robertson · Director
  • Charles W. Larson · Director
  • Christopher A. Kroeger · Director
  • James W. Garvey · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen W. Sagon, President. Source: SEC Form D, newest notice filed May 9, 2014. Read the notice at the SEC.

equity, debtSEC
Feb 2011$14 MNo. 3$10 to $50 million

CardioFocus, Inc.: Raise no. 3, Feb 2011

Investors in this round

25 investors had bought by the notice of Feb 24, 2011: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $16 M offered; $2 M still to sell
Smallest investment taken
$2,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen W. Sagon · Executive Officer, Director
  • Bruce A. Robertson · Director
  • Charles A. Larsen · Director
  • Christopher A. Kroeger · Director
  • James A. Garvey · Director
  • Omar A. Amirana · Director
  • Paul A. LaViolette · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen W. Sagon, President. Source: SEC Form D, newest notice filed Feb 24, 2011. Read the notice at the SEC.

equitySEC
Apr 2010$5 MNo. 2$2 to $10 million

CardioFocus, Inc.: Raise no. 2, Apr 2010

Investors in this round

13 investors had bought by the notice of Apr 20, 2010: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$5,000
What was sold
equity, debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Sagon · Executive Officer, Director
  • Bruce Robertson · Director
  • Charles Larsen · Director
  • Christopher Kroeger · Director
  • James Garvey · Director
  • John Schulte · Director
  • Marlene Krauss · Director
  • Omar Amirana · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lauren Jennings, Secretary. Source: SEC Form D, newest notice filed Apr 20, 2010. Read the notice at the SEC.

equity, debt, optionsSEC
Jun 2009$6 MNo. 1$2 to $10 million

CardioFocus, Inc.: Raise no. 1, Jun 2009

Investors in this round

19 investors had bought by the notice of Jun 25, 2009: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $9 M offered; $3 M still to sell
Smallest investment taken
$5,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Sagon · Executive Officer, Director
  • Bruce C. Robertson · Director
  • Charles E. Larsen · Director
  • Christopher A. Kroeger · Director
  • James Garvey · Director
  • John Schulte · Director
  • Marlene Krauss · Director
  • Omar Amirana · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lauren Jennings, Secretary. Source: SEC Form D, newest notice filed Jun 25, 2009. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • CardioFocus, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2023).

    SEC Form D · Feb 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Feb 2023

That is all the official record says: CardioFocus, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

In its own words

How the company describes itself to search engines on its website, word for word.

“CardioFocus provides electrophysiologists with innovative tools for the treatment of atrial fibrillation.”

Source: The company's website · as of Nov 15, 2026

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of CardioFocus, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 13 rounds above had up to 32 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by CardioFocus, Inc.
NameRoleNamed in
Scott FletcherExecutive officerFeb 2023
Stephan OgilvieExecutive officerFeb 2023
Burke BarrettExecutive officerApr 2022
Burke C. BarrettExecutive officerMay 2019
Omari C. BouknightExecutive officerMay 2019
Burke R. BarrettExecutive officerApr 2018
Paul C. LavioletteExecutive officerApr 2018
Warren R. Clark, IiiExecutive officerApr 2018
Burke J. BarrettExecutive officerMar 2017
Warren C. Clark, IiiExecutive officerMar 2017
Anjie RoldanExecutive officerJan 2015
Lauren JenningsExecutive officerJan 2015
Paul LaVioletteExecutive officerJan 2015
Stephen SagonExecutive officerJan 2015
Warren ClarkExecutive officerJan 2015
Stephen W SagonExecutive officerNov 2014
Warren R Clark IIIExecutive officerNov 2014
David R. KresslerDirector of Medical DevicesMay 2014
Paul W. LavioletteExecutive officerMay 2014
Stephen W. SagonExecutive officerMay 2014
Warren R. Clark IIIExecutive officerMay 2014
Bruce RobertsonDirectorFeb 2023
Charles LarsenDirectorFeb 2023
David KhoDirectorFeb 2023
Gwen WatanabeDirectorFeb 2023
Burke BarrettDirectorApr 2022
Omar AmiranaDirectorApr 2022
Patrick WethingtonDirectorApr 2022
Paul LaVioletteDirectorApr 2022
Bruce C. RobertsonDirectorMay 2019
Charles E. LarsenDirectorMay 2019
Christopher A. KroegerDirectorMay 2019
Greg C. MaddenDirectorMay 2019
Omar C. AmiranaDirectorMay 2019
Patrick C. WethingtonDirectorMay 2019
Paul C. LavioletteDirectorMay 2019
Greg R. MaddenDirectorApr 2018
Patrick R. WethingtonDirectorApr 2018
Christopher KroegerDirectorMar 2017
James GarveyDirectorMar 2017

About

Company in Marlborough, United States.